ID: ALA5076622

Max Phase: Preclinical

Molecular Formula: C44H55N7O6S

Molecular Weight: 810.03

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCC(=O)Nc2ccc(C(=O)Nc3ccccc3N)cc2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C44H55N7O6S/c1-28-39(58-27-47-28)30-18-16-29(17-19-30)25-46-42(56)36-24-33(52)26-51(36)43(57)40(44(2,3)4)50-38(54)15-9-7-5-6-8-14-37(53)48-32-22-20-31(21-23-32)41(55)49-35-13-11-10-12-34(35)45/h10-13,16-23,27,33,36,40,52H,5-9,14-15,24-26,45H2,1-4H3,(H,46,56)(H,48,53)(H,49,55)(H,50,54)/t33-,36+,40-/m1/s1

Standard InChI Key:  XXPSDQVUSUURLT-KTHCSKACSA-N

Associated Targets(Human)

VHL/Histone deacetylase 1 90 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 2 81 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

VHL/Histone deacetylase 3 77 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 810.03Molecular Weight (Monoisotopic): 809.3935AlogP: 6.43#Rotatable Bonds: 17
Polar Surface Area: 195.85Molecular Species: NEUTRALHBA: 9HBD: 6
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 4
CX Acidic pKa: 12.56CX Basic pKa: 3.24CX LogP: 4.41CX LogD: 4.41
Aromatic Rings: 4Heavy Atoms: 58QED Weighted: 0.05Np Likeness Score: -0.72

References

1. Smalley JP, Baker IM, Pytel WA, Lin LY, Bowman KJ, Schwabe JWR, Cowley SM, Hodgkinson JT..  (2022)  Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells.,  65  (7.0): [PMID:35293758] [10.1021/acs.jmedchem.1c02179]

Source